Welcome to the Adaflex (melatonin)

Are you a healthcare professional in the UK, a parent/patient who has been prescribed Adaflex or a member of the general public?

Please select the appropriate button to be directed to suitable resources.

Reporting adverse events
If you get any side-effects, talk to your doctor, nurse or pharmacist. This includes any possible side-effects not listed in the package leaflet. You can also report side-effects directly via the Yellow Card scheme at By reporting side-effects you can help provide more information on the safety of medicines. Adverse events should also be reported AGB-Pharma at:

This area of the site is intended for UK residents only. In this area of the site, you will find relevant information and links to other websites that may be of interest.

This information is not intended as a substitute for the advice of a qualified health professional. If you have concerns about your health or the treatment you are receiving, we would encourage you to speak to your doctor, pharmacist or another health professional.

UK-MEL-AGB 0085. Date of preparation: April 2024.
©2024 AGB-Pharma AB (EN).